Bundeswehr Institute of Microbiology

Last updated
Bundeswehr Institute of Microbiology
InstMikroBioBw Wappen.jpg
IMB coat of arms
Active1984–present
CountryFlag of Germany.svg  Germany
TypeMedical CBRN defence institute
RoleMedical biodefence research and development
Part of Bundeswehr biological defense program
Garrison/HQErnst-von-Bergmann Barracks
Commanders
Current
commander
Colonel Prof. Dr. Roman Wölfel

The Bundeswehr Institute of Microbiology (IMB, military abbreviation InstMikroBioBw) in Munich is the German Armed Forces' scientific competence center in the field of medical defense against biological warfare agents and other dangerous pathogens or biotoxins. The institute provides procedures and methods for the rapid and unambiguous identification and verification of allegations of the use of biological warfare agents, conducts specialized training, and participates in the development of medical biodefense concepts and strategies.

Contents

Tasks

Directors

History

The institute was established in 1966 as the Microbiology Laboratory Group at the Medical Corps School of the Bundeswehr (now: Bundeswehr Medical Academy) in Munich. In 1984, today's Bundeswehr Institute of Microbiology was officially founded as an independent military unit. It has been stationed in the Ernst-von-Bergmann barracks in the north of Munich ever since.

In response to the September 11 attacks in 2001, the German Council of Science and Humanities recommended that the Bundeswehr Institute of Microbiology be developed into a national military competence center for biodefense. [1]

The institute provides medical diagnostics for biological warfare agents and naturally occurring infectious agents of military importance for all members of the Bundeswehr. These services include infectious agents of biological risk groups 3 and 4 and are also available to civilian healthcare facilities. In September 2012, the Central Diagnostic Department (ZBD) of the Institute was flexibly accredited by the German Accreditation Body according to ISO 15189.

In August 2002, along with the Bundeswehr Institute of Radiobiology and the Bundeswehr Institute of Pharmacology and Toxicology, the institute became an independent entity under the Central Medical Service of the Bundeswehr and was placed under the supervision of the Bundeswehr Medical Office. Since 2012, all three institutes have once again been under the military command of the Medical Academy, but now as independent military units at battalion level.

Since 2010, the institute, together with the Technical University of Munich, the Ludwig Maximilian University of Munich, and the Helmholtz Zentrum München, forms the partner site in Munich of the German Center for Infection Research (DZIF). In February 2013, the cooperation with the Institute of Microbiology, Immunology, and Hygiene and the Institute of Virology of the TU Munich began. In 2016, a cooperation agreement was signed with the University of Stuttgart-Hohenheim. [2]

Since 2009, the Medical Biodefense Conference [3] has been organized in the format of an international conference. [4]

The Bundeswehr Institute for Microbiology has been leading the development of a modular and rapidly deployable mobile laboratory system for the German Armed Forces since 2007. The institute's mobile lab systems are crafted to deliver a prompt response to sudden disease outbreaks, featuring adaptable configurations and cutting-edge biosafety measures. [5] The incorporation of a collapsible glove box with sturdy polycarbonate walls [6] ensures a secure working environment for handling highly infectious samples. Leveraging diagnostic technologies like qPCR, ELISA, and NGS, the system aims for expeditious turnaround times in sample analysis. With minimal infrastructure requirements, it can be rapidly deployed worldwide and utilized across diverse environments. Following initial deployments in the Balkans, the mobile laboratory seamlessly integrated into the European Mobile Lab Project (EMLab) from 2013. Remarkably, these systems played a pivotal role during the 2014 Ebola outbreak in West Africa and are now acknowledged as a global technical standard for diagnostic field operations in combating disease outbreaks. [7]

The Bundeswehr Institute of Microbiology reached a significant milestone during the COVID-19 pandemic. [8] On January 27, 2020, researchers at the institute diagnosed the first cases of illness caused by the SARS-CoV-2 virus in Germany, marking a pivotal early detection in the laboratory. [9] Notably, the institute successfully cultured the virus in cell cultures, achieving a feat previously only accomplished by Australian researchers outside of China. Furthermore, the research group sequenced the genome of SARS-CoV-2, providing comprehensive insights beyond the partial information available from Chinese online transmissions. The institute offered the initial description of the replication of SARS-CoV-2 in the nasal and throat cavity and the excretion of the virus in the stool. [10]

On May 19, 2022, amidst the largest outbreak of mpox in Europe to date, the Bundeswehr Institute of Microbiology confirmed the first case of mpox in Germany. [11]

Related Research Articles

<span class="mw-page-title-main">Biological warfare</span> Use of strategically designed biological weapons

Biological warfare, also known as germ warfare, is the use of biological toxins or infectious agents such as bacteria, viruses, insects, and fungi with the intent to kill, harm or incapacitate humans, animals or plants as an act of war. Biological weapons are living organisms or replicating entities. Entomological (insect) warfare is a subtype of biological warfare.

<span class="mw-page-title-main">Bioterrorism</span> Terrorism involving biological agents

Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents include bacteria, viruses, insects, fungi, and/or their toxins, and may be in a naturally occurring or a human-modified form, in much the same way as in biological warfare. Further, modern agribusiness is vulnerable to anti-agricultural attacks by terrorists, and such attacks can seriously damage economy as well as consumer confidence. The latter destructive activity is called agrobioterrorism and is a subtype of agro-terrorism.

Biodefense refers to measures to counter biological threats, reduce biological risks, and prepare for, respond to, and recover from bioincidents, whether naturally occurring, accidental, or deliberate in origin and whether impacting human, animal, plant, or environmental health. Biodefense measures often aim to improve biosecurity or biosafety. Biodefense is frequently discussed in the context of biological warfare or bioterrorism, and is generally considered a military or emergency response term.

<span class="mw-page-title-main">Biosafety level</span> Set of biocontainment precautions

A biosafety level (BSL), or pathogen/protection level, is a set of biocontainment precautions required to isolate dangerous biological agents in an enclosed laboratory facility. The levels of containment range from the lowest biosafety level 1 (BSL-1) to the highest at level 4 (BSL-4). In the United States, the Centers for Disease Control and Prevention (CDC) have specified these levels in a publication referred to as BMBL. In the European Union, the same biosafety levels are defined in a directive. In Canada the four levels are known as Containment Levels. Facilities with these designations are also sometimes given as P1 through P4, as in the term P3 laboratory.

Viral load, also known as viral burden, is a numerical expression of the quantity of virus in a given volume of fluid, including biological and environmental specimens. It is not to be confused with viral titre or viral titer, which depends on the assay. When an assay for measuring the infective virus particle is done, viral titre often refers to the concentration of infectious viral particles, which is different from the total viral particles. Viral load is measured using body fluids sputum and blood plasma. As an example of environmental specimens, the viral load of norovirus can be determined from run-off water on garden produce. Norovirus has not only prolonged viral shedding and has the ability to survive in the environment but a minuscule infectious dose is required to produce infection in humans: less than 100 viral particles.

<span class="mw-page-title-main">American Society for Microbiology</span> American scholarly society focused on microbiology

The American Society for Microbiology (ASM), originally the Society of American Bacteriologists, is a professional organization for scientists who study viruses, bacteria, fungi, algae, and protozoa as well as other aspects of microbiology. It was founded in 1899. The Society publishes a variety of scientific journals, textbooks, and other educational materials related to microbiology and infectious diseases. ASM organizes annual meetings, as well as workshops and professional development opportunities for its members.

The United States Army Medical Research Institute of Chemical Defense (USAMRICD) is a military medical research institute located at Aberdeen Proving Ground, Maryland, US. It is the leading science and technology laboratory of the Department of Defense for the development, testing, and evaluation of medical chemical warfare countermeasures including therapies and materials to treat casualties of chemical warfare agents.

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

The National Microbiology Laboratory (NML) is part of the Public Health Agency of Canada (PHAC), the agency of the Government of Canada that is responsible for public health, health emergency preparedness and response, and infectious and chronic disease control and prevention.

<span class="mw-page-title-main">State Research Center of Virology and Biotechnology VECTOR</span> Russian government public health agency

The State Research Center of Virology and Biotechnology VECTOR, also known as the Vector Institute, is a biological research center in Koltsovo, Novosibirsk Oblast, Russia. It has research facilities and capabilities for all levels of biological hazard, CDC levels 1–4. It is one of two official repositories for the now-eradicated smallpox virus, and was part of the system of laboratories known as the Biopreparat.

<span class="mw-page-title-main">United States Army Medical Research Institute of Infectious Diseases</span> U.S. Army counter-biological warfare research institution

The United States Army Medical Research Institute of Infectious Diseases is the U.S Army's main institution and facility for defensive research into countermeasures against biological warfare. It is located on Fort Detrick, Maryland, near Washington, D.C., and is a subordinate lab of the United States Army Medical Research and Development Command (USAMRDC), headquartered on the same installation.

<span class="mw-page-title-main">Rudi Pauwels</span> Belgian pharmacologist and entrepreneur

Rudi Pauwels is a Belgian pharmacologist and biotech entrepreneur.

<span class="mw-page-title-main">Soviet biological weapons program</span> Russian bioweapons program from 1920s to 1990s

The Soviet Union covertly operated the world's largest, longest, and most sophisticated biological weapons program, thereby violating its obligations as a party to the Biological Weapons Convention of 1972. The Soviet program began in the 1920s and lasted until at least September 1992 but has possibly been continued by Russian Federation after that.

The National Institute of Virology in Pune, India is an Indian virology research institute and part of the Indian Council of Medical Research (ICMR). It was previously known as 'Virus Research Centre' and was founded in collaboration with the Rockefeller Foundation. It has been designated as a WHO H5 reference laboratory for SE Asia region.

Clarence James Peters, Jr is a physician, field virologist and former U.S. Army colonel. He is noted for his efforts in trying to stem epidemics of exotic infectious diseases such as the Ebola virus, Hanta virus and Rift Valley fever (RVF). He is an eminent authority on the virology, pathogenesis and epidemiology of hemorrhagic fever viruses.

<span class="mw-page-title-main">Aeromedical Isolation Team</span> Former US Army aeromobile biocontainment team

The Aeromedical Isolation Team of the US Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland was a military rapid response team with worldwide airlift capability designed to safely evacuate and manage contagious patients under high-level (BSL-4) bio-containment conditions. Created in 1978, during its final years the AIT was one of MEDCOM’s Special Medical Augmentation Response Teams comprising a portable containment laboratory along with its transit isolators for patient transport. Contingency missions included bioterrorism scenarios as well as the extraction of scientists with exotic infections from remote sites in foreign countries. The AIT trained continuously and was often put on alert status, but only deployed for “real world” missions four times. The AIT was decommissioned in 2010 and its mission was assumed by one of the US Air Force’s Critical Care Air Transport Teams (CCATTs).

The United States Biological Defense Program—in recent years also called the National Biodefense Strategy—refers to the collective effort by all levels of government, along with private enterprise and other stakeholders, in the United States to carry out biodefense activities.

Christopher Mores is an American (US) arbovirologist, trained in infectious disease epidemiology. He is a professor in the Department of Global Health at the Milken Institute School of Public Health, the program director for the Global Health Epidemiology and Disease Control MPH program, and is director of a high-containment research laboratory at the George Washington University in Washington, DC.

The National Institute of Virology (NIV) in Pakistan is a national research institute concentrating on biosafety. It has a national laboratory site dedicated to identification and eradication of Emerging infectious diseases, as well as efforts in biological warfare. The aforementioned is a BSL3 laboratory managed by the University of Karachi for the Ministry of Health. Karachi University's International Center for Chemical and Biological Sciences established the National Institute of Virology on September 19, 2019.

<span class="mw-page-title-main">Roman Woelfel</span> German physician, virologist and Bundeswehr colonel

Roman Wölfel [roˈmaːn ˈvœlfl̩] is a German physician and medical officer in the rank of Colonel (OF-5) in the German Armed Forces (Bundeswehr). Since October 2019, he is the director of the Bundeswehr Institute of Microbiology in Munich and since 2021 a professor at the Technical University of Munich (TUM).

References

  1. Scientific policy statement on the Bundeswehr Institute of Microbiology, Munich (PDF) (in German). Berlin: German Council of Science and Humanities. 2007-01-26.{{cite book}}: CS1 maint: date and year (link)
  2. InstMikroBioBw: History
  3. "MBDC2023 – Medical Biodefense Conference" (in German). Retrieved 2023-12-03.
  4. Institute of Microbiology of the Bundeswehr: Medical Biodefense Conference
  5. Wölfel, Roman; Stoecker, Kilian; Fleischmann, Erna; Gramsamer, Brigitte; Wagner, Matthias; Molkenthin, Peter; Caro, Antonino Di; Günther, Stephan; Ibrahim, Sofi; Genzel, Gelimer H.; Ozin-Hofsäss, Amanda J.; Formenty, Pierre; Zöller, Lothar (2015-11-05). "Mobile diagnostics in outbreak response, not only for Ebola: a blueprint for a modular and robust field laboratory". Eurosurveillance. 20 (44): 30055. doi: 10.2807/1560-7917.ES.2015.20.44.30055 . ISSN   1560-7917. PMID   26559006.
  6. "Espacenet – search results". worldwide.espacenet.com. Retrieved 2023-12-03.
  7. "Guidance for rapid response mobile laboratory (RRML) classification". www.who.int. Retrieved 2023-12-03.
  8. "Coronavirus: Münchener Institut erbringt Nachweis". www.bundeswehr.de (in German). 2020-01-29. Retrieved 2023-12-03.
  9. Rothe, Camilla; Schunk, Mirjam; Sothmann, Peter; Bretzel, Gisela; Froeschl, Guenter; Wallrauch, Claudia; Zimmer, Thorbjörn; Thiel, Verena; Janke, Christian; Guggemos, Wolfgang; Seilmaier, Michael; Drosten, Christian; Vollmar, Patrick; Zwirglmaier, Katrin; Zange, Sabine (2020-03-05). "Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany". New England Journal of Medicine. 382 (10): 970–971. doi:10.1056/NEJMc2001468. ISSN   0028-4793. PMC   7120970 . PMID   32003551.
  10. Wölfel, Roman; Corman, Victor M.; Guggemos, Wolfgang; Seilmaier, Michael; Zange, Sabine; Müller, Marcel A.; Niemeyer, Daniela; Jones, Terry C.; Vollmar, Patrick; Rothe, Camilla; Hoelscher, Michael; Bleicker, Tobias; Brünink, Sebastian; Schneider, Julia; Ehmann, Rosina (2020-05-28). "Virological assessment of hospitalized patients with COVID-2019". Nature. 581 (7809): 465–469. Bibcode:2020Natur.581..465W. doi: 10.1038/s41586-020-2196-x . ISSN   0028-0836. PMID   32235945. S2CID   214771224.
  11. Noe, Sebastian; Zange, Sabine; Seilmaier, Michael; Antwerpen, Markus H.; Fenzl, Thomas; Schneider, Jochen; Spinner, Christoph D.; Bugert, Joachim J.; Wendtner, Clemens-Martin; Wölfel, Roman (February 2023). "Clinical and virological features of first human monkeypox cases in Germany". Infection. 51 (1): 265–270. doi:10.1007/s15010-022-01874-z. ISSN   0300-8126. PMC   9272654 . PMID   35816222.